Yahoo Web Search

Search results

1. www.biogen.comHome | Biogen

   www.biogen.com

   • Cached

   Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...

   • Pipeline

     Breaking New Ground With Science. With a strong focus on...

     Careers

     · Company

     · Multiple Sclerosis (MS)

     · Leadership Team

     · Disease Areas

     · Medicines

   • News Releases

     New Data from Biogen’s Investigational Antisense...

   • Contact Us

     Alzheimer’s Support Alzheimer’s Support Services...

   • Investor Relations

     Founded in 1978, Biogen is a leading global biotechnology...

   • Responsibility

     For Biogen, that includes bolstering our commitment to...

2. Top Stories

   • 

     Bloomberg L.P.

     Biogen to Pay Up to $1.8 Billion for Immune Drug Developer

     1 week ago

   • Business Insider

     Lost Money on Biogen Inc. (BIIB)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

     NEW YORK, NY / ACCESSWIRE / May 28, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the ...

     16 hours ago

   • 

     Business Insider

     Deep Dive Into Biogen Stock: Analyst Perspectives (17 Ratings)

     1 week ago

   • The Boston Globe on MSN.com

     Biogen buys California biotech for $1.15 billion

     1 week ago

   • Quartz on MSN.com

     Biogen is buying up an immune drug developer for $1.8 billion

     1 week ago

   View all

3. Images

   • 
   • 
   • 

   View all

4. www.biogen.com › companyCompany | Biogen

   www.biogen.com › company

   • Cached

   Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...

5. en.wikipedia.org › wiki › BiogenBiogen - Wikipedia

   en.wikipedia.org › wiki › Biogen

   • Cached

   Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan ...

6. Videos

   • 

     3:08

     youtube.com

     Perks of Biogen

     Nov 7, 2023

     1.4K Views

   • 

     1:30

     youtube.com

     Biogen Idec is Biogen, Once Again

     Mar 23, 2015

     5.9K Views

   • 

     16:02

     youtube.com

     What’s The Controversy Behind Biogen’s Alzheimer’s Drug?

     Jan 4, 2022

     277K Views

   View all

7. www.nytimes.com › 2023/04/25 › businessFDA Approves Biogen’s Drug for Rare Form of ALS - The New ...

   www.nytimes.com › 2023/04/25 › business

   Apr 25, 2023 · By Rebecca Robbins. April 25, 2023. The Food and Drug Administration on Tuesday authorized the first drug for a rare genetic form of the neurological disorder A.L.S., despite uncertainty about the...

8. www.biogen.com › science-and-innovationScience & Innovation | Biogen

   www.biogen.com › science-and-innovation

   • Cached

   The potential to transform the lives of patients is what drives us at Biogen. As a leading global biotechnology company, we work toward those once-in-a-lifetime moments that could become a historic point in our pursuit of innovative treatments.

9. People also ask

   Who is Biogen?

   • Company Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases.

   Company | Biogen

   www.biogen.com/company.html

   See all results for this question

   Who is Biogen & why should you care?

   • Founded in 1978, Biogen has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Where science meets humanity

   Company | Biogen

   www.biogen.com/company.html

   See all results for this question

   Why should you choose Biogen for a rare disease treatment?

   • Biogen is proud to leverage our expertise in rare diseases to build on the outstanding work Reata has done to launch the first and only U.S. Food and Drug Administration (FDA) and European Commission (EC) approved treatment for FA in adults and adolescents aged 16 years and older.

   Science & Innovation | Biogen

   www.biogen.com/science-and-innovation.html

   See all results for this question

   Is Biogen a stock?

   • Biogen stock is a component of several stock indices such as the S&P 500, S&P 1500, and NASDAQ-100 and the company is listed on the NASDAQ stock exchange under the ticker symbol, BIIB. In May 2006, the company announced it would acquire cancer specialist, Conforma Therapeutics for $250 million.

   Biogen - Wikipedia

   en.wikipedia.org/wiki/Biogen

   See all results for this question

10. www.biogen.com › science-and-innovation › pipelinePipeline | Biogen

    www.biogen.com › science-and-innovation › pipeline

    • Cached

    Breaking New Ground With Science. With a strong focus on difficult-to-treat diseases, our pipeline is focused on research in therapeutic areas where we believe we have the best opportunity to deliver transformational medicines to patients and protect public health.

11. investors.biogen.comBiogen | Investor Relations

    investors.biogen.com

    • Cached

    May 16, 2024 · Biogen is a global biotechnology company that develops and commercializes therapies for neurology, neuropsychiatry, immunology and rare diseases. Find out about its corporate profile, financial results, news, events and investor resources.